An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation-Reference-Cited by-同舟云学术

An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation

Published:2010-06 Issue:12 Volume:79 Page:1772-1780
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Lui Vivian Wai Yan,Lau Cecilia Pik Yuk,Cheung Crystal Sao Fong,Ho Kakiu,Ng Margaret Heung Ling,Cheng Suk Hang,Hong Bo,Tsao Sai-Wah,Tsang Chi Man,Lei Kenny Ieng Kit,Yamasaki Yasundo,Mita Akira,Chan Anthony T.C.

Funder

Taiho Pharmaceutical Co., Ltd.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference39 articles.

1. Ribozymes and siRNAs: from structure to preclinical applications;Sioud;Handb Exp Pharmacol,2006

2. Destroying RNA as a therapeutic approach;Tafech;Curr Med Chem,2006

3. Flavopiridol, an inhibitor of transcription: implications, problems and solutions;Blagosklonny;Cell Cycle,2004

4. Transcriptional inhibitors, p53 and apoptosis;Gartel;Biochim Biophys Acta,2008

5. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1;MacCallum;Cancer Res,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIGAR Ameliorates Pulmonary Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway;J BIOL REG HOMEOS AG;2023

2. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies;Antioxidants;2022-03-30

3. Advance of structural modification of nucleosides scaffold;European Journal of Medicinal Chemistry;2021-03

4. TIGAR Promotes Tumorigenesis and Protects Tumor Cells From Oxidative and Metabolic Stresses in Gastric Cancer;Frontiers in Oncology;2019-11-19

5. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer;Current Cancer Drug Targets;2019-08-02